ApoE mimetic reduces plasma lipid hydroperoxide content with a concomitant increase in HDL paraoxonase activityGeeta Datta, , Manjula Chaddha , Shaila P. Handattu, Mayakonda N. Palgunachari, Gaurav Nayyar, David W. Garber, Himanshu Gupta, C. Roger White and G.M. AnantharamaiahInterrelationships between paraoxonase-1 and monocyte chemoattractant protein-1 in the regulation of hepatic inflammationJordi Camps, Judit Marsillach, Anna Rull, Carlos Alonso-Villaverde, and Jorge JovenBiomarkers of Sensitivity and Exposure in Washington State Pesticide HandlersJN Hofmann, MC Keifer, H Checkoway, AJ De Roos, FM Farin FM, RA Fenske, RJ Richter, G van Belle, CE FurlongParaoxonase 1 (PON1) Status as a Risk Factor for Disease or ExposureRebecca J Richter, Gail P Jarvik, Clement E FurlongEngineering Human PON1 in an E. coli Expression System.Stephanie M. Suzuki, Richard C. Stevens, Rebecca J. Richter, Toby B. Cole, Sarah Park, Tamara C. Otto, Douglas M. Cerasoli, David E. Lenz and Clement E. FurlongThe Toxicity of Mixtures of Specific Organophosphorus (OP) Compounds is Modulated by Paraoxonase 1 (PON1) Status.Toby B. Cole, Karen Jansen, Sarah Park, Wan-Fen Li, Clement E. Furlong, and Lucio G. CostaIdentification and Characterization of Biomarkers of Organophosphorus (OP) Exposures in HumansJerry H. Kim, Richard C. Stevens, Michael J. MacCoss, David R. Goodlett, Alex Scherl, Rebecca J. Richter, Stephanie M. Suzuki, Clement E. FurlongTemporal and tissue-specific patterns of Pon3 expression in mouse: in situ hybridization analysisDiana M. Shih, Yu-Rong Xia, Janet M. Yu, and Aldons J. LusisPON1 and Oxidative Stress in Human Sepsis and an Animal Model of SepsisDragomir Draganov, John Teiber, Catherine Watson, Charles Bisgaier, Jean Nemzek, Daniel Remeck, Theodore Standiford, Bert La DUParaoxonase 1 attenuates human plaque atherogenicity: Relevance to the enzyme lactonase activity.Hagai Tavori, Jacob Vaya, Michael AviramThe role of Paraoxonase 1 in the detoxification of homocysteine thilĂ~